Industry: Medical Devices & Consumables
Published Date: 2024-04-16
Pages: 136 Pages
Report ld: 2685093
Request Sample
Customized Report
Total Artificial Heart Market Size(US$)

CAGR 2024-2030
21.7%
Market Size,2030
USD 156.5
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
The global Total Artificial Heart market is projected to reach US$ 156.5 million by 2030 from an estimated US$ 48 million in 2024, at a CAGR of 21.7% during 2024 and 2030.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Total Artificial Heart, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Total Artificial Heart.
The Total Artificial Heart market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Total Artificial Heart market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Total Artificial Heart manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Total Artificial Heart in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Total Artificial Heart sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Total Artificial Heart Product Introduction
1.2 Market by Type
1.2.1 Global Total Artificial Heart Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 SynCardia
1.2.3 Others
1.3 Market by Application
1.3.1 Global Total Artificial Heart Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Dilated Cardiomyopathy
1.3.3 Ischemic Cardiomyopathy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Total Artificial Heart Market Size Estimates and Forecasts
2.1.1 Global Total Artificial Heart Revenue 2019-2030
2.1.2 Global Total Artificial Heart Sales 2019-2030
2.2 Total Artificial Heart Market Size by Region: 2023 Versus 2030
2.3 Total Artificial Heart Sales by Region (2019-2030)
2.3.1 Global Total Artificial Heart Sales by Region: 2019-2024
2.3.2 Global Total Artificial Heart Sales Forecast by Region (2025-2030)
2.3.3 Global Total Artificial Heart Sales Market Share by Region (2019-2030)
2.4 Total Artificial Heart Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Total Artificial Heart Revenue by Region: 2019-2024
2.4.2 Global Total Artificial Heart Revenue Forecast by Region (2025-2030)
2.4.3 Global Total Artificial Heart Revenue Market Share by Region (2019-2030)
3 Global Total Artificial Heart by Manufacturers
3.1 Global Top Total Artificial Heart Manufacturers by Sales
3.1.1 Global Total Artificial Heart Sales by Manufacturer (2019-2024)
3.1.2 Global Total Artificial Heart Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Total Artificial Heart Manufacturers by Revenue
3.2.1 Global Total Artificial Heart Revenue by Manufacturer (2019-2024)
3.2.2 Global Total Artificial Heart Revenue Share by Manufacturer (2019-2024)
3.3 Global Total Artificial Heart Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Total Artificial Heart Manufacturers Covered: Ranking by Revenue
3.4.2 Global Total Artificial Heart Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Total Artificial Heart Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Total Artificial Heart Manufacturing Base Distribution, Product Type
3.5.1 Total Artificial Heart Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Total Artificial Heart Product Type
3.5.3 Date of International Manufacturers Enter into Total Artificial Heart Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 BiVACOR
4.1.1 BiVACOR Company Information
4.1.2 BiVACOR Description, Business Overview
4.1.3 BiVACOR Total Artificial Heart Products Offered
4.1.4 BiVACOR Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
4.1.5 BiVACOR Total Artificial Heart Sales by Product in 2023
4.1.6 BiVACOR Total Artificial Heart Sales by Application in 2023
4.1.7 BiVACOR Total Artificial Heart Sales by Geographic Area in 2023
4.1.8 BiVACOR Recent Developments
4.2 SynCardia
4.2.1 SynCardia Company Information
4.2.2 SynCardia Description, Business Overview
4.2.3 SynCardia Total Artificial Heart Products Offered
4.2.4 SynCardia Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
4.2.5 SynCardia Total Artificial Heart Sales by Product in 2023
4.2.6 SynCardia Total Artificial Heart Sales by Application in 2023
4.2.7 SynCardia Total Artificial Heart Sales by Geographic Area in 2023
4.2.8 SynCardia Recent Developments
4.3 Jarvik Heart
4.3.1 Jarvik Heart Company Information
4.3.2 Jarvik Heart Description, Business Overview
4.3.3 Jarvik Heart Total Artificial Heart Products Offered
4.3.4 Jarvik Heart Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Jarvik Heart Total Artificial Heart Sales by Product in 2023
4.3.6 Jarvik Heart Total Artificial Heart Sales by Application in 2023
4.3.7 Jarvik Heart Total Artificial Heart Sales by Geographic Area in 2023
4.3.8 Jarvik Heart Recent Developments
4.4 CARMAT
4.4.1 CARMAT Company Information
4.4.2 CARMAT Description, Business Overview
4.4.3 CARMAT Total Artificial Heart Products Offered
4.4.4 CARMAT Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
4.4.5 CARMAT Total Artificial Heart Sales by Product in 2023
4.4.6 CARMAT Total Artificial Heart Sales by Application in 2023
4.4.7 CARMAT Total Artificial Heart Sales by Geographic Area in 2023
4.4.8 CARMAT Recent Developments
4.5 AbioMed
4.5.1 AbioMed Company Information
4.5.2 AbioMed Description, Business Overview
4.5.3 AbioMed Total Artificial Heart Products Offered
4.5.4 AbioMed Total Artificial Heart Sales, Revenue and Gross Margin (2019-2024)
4.5.5 AbioMed Total Artificial Heart Sales by Product in 2023
4.5.6 AbioMed Total Artificial Heart Sales by Application in 2023
4.5.7 AbioMed Total Artificial Heart Sales by Geographic Area in 2023
4.5.8 AbioMed Recent Developments
5 Breakdown Data by Type
5.1 Global Total Artificial Heart Sales by Type (2019-2030)
5.1.1 Global Total Artificial Heart Sales by Type (2019-2024)
5.1.2 Global Total Artificial Heart Sales Forecast by Type (2025-2030)
5.1.3 Global Total Artificial Heart Sales Market Share by Type (2019-2030)
5.2 Global Total Artificial Heart Revenue Forecast by Type (2019-2030)
5.2.1 Global Total Artificial Heart Revenue by Type (2019-2024)
5.2.2 Global Total Artificial Heart Revenue Forecast by Type (2025-2030)
5.2.3 Global Total Artificial Heart Revenue Market Share by Type (2019-2030)
5.3 Total Artificial Heart Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Total Artificial Heart Sales by Application (2019-2030)
6.1.1 Global Total Artificial Heart Sales by Application (2019-2024)
6.1.2 Global Total Artificial Heart Sales Forecast by Application (2025-2030)
6.1.3 Global Total Artificial Heart Sales Market Share by Application (2019-2030)
6.2 Global Total Artificial Heart Revenue Forecast by Application (2019-2030)
6.2.1 Global Total Artificial Heart Revenue by Application (2019-2024)
6.2.2 Global Total Artificial Heart Revenue Forecast by Application (2025-2030)
6.2.3 Global Total Artificial Heart Revenue Market Share by Application (2019-2030)
6.3 Total Artificial Heart Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Total Artificial Heart Market Size YoY Growth 2019-2030
7.2 North America Total Artificial Heart Market Facts & Figures by Country
7.2.1 North America Total Artificial Heart Sales by Country (2019-2030)
7.2.2 North America Total Artificial Heart Revenue by Country (2019-2030)
7.3 North America Total Artificial Heart Sales by Type (2019-2024)
7.4 North America Total Artificial Heart Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Total Artificial Heart Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Total Artificial Heart Market Facts & Figures by Region
8.2.1 Asia-Pacific Total Artificial Heart Sales by Region (2019-2030)
8.2.2 Asia-Pacific Total Artificial Heart Revenue by Region (2019-2030)
8.3 Asia-Pacific Total Artificial Heart Sales by Type (2019-2024)
8.4 Asia-Pacific Total Artificial Heart Sales by Application (2019-2024)
9 Europe
9.1 Europe Total Artificial Heart Market Size YoY Growth 2019-2030
9.2 Europe Total Artificial Heart Market Facts & Figures by Country
9.2.1 Europe Total Artificial Heart Sales by Country (2019-2030)
9.2.2 Europe Total Artificial Heart Revenue by Country (2019-2030)
9.3 Europe Total Artificial Heart Sales by Type (2019-2024)
9.4 Europe Total Artificial Heart Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Total Artificial Heart Market Size YoY Growth 2019-2030
10.2 Latin America Total Artificial Heart Market Facts & Figures by Country
10.2.1 Latin America Total Artificial Heart Sales by Country (2019-2030)
10.2.2 Latin America Total Artificial Heart Revenue by Country (2019-2030)
10.3 Latin America Total Artificial Heart Sales by Type (2019-2024)
10.4 Latin America Total Artificial Heart Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Total Artificial Heart Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Total Artificial Heart Market Facts & Figures by Country
11.2.1 Middle East and Africa Total Artificial Heart Sales by Country (2019-2030)
11.2.2 Middle East and Africa Total Artificial Heart Revenue by Country (2019-2030)
11.3 Middle East and Africa Total Artificial Heart Sales by Type (2019-2024)
11.4 Middle East and Africa Total Artificial Heart Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Total Artificial Heart Supply Chain Analysis
12.2 Total Artificial Heart Key Raw Materials and Upstream Suppliers
12.3 Total Artificial Heart Clients Analysis
12.4 Total Artificial Heart Sales Channel and Sales Model Analysis
12.4.1 Total Artificial Heart Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Total Artificial Heart Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Total Artificial Heart Distributors
13 Market Dynamics
13.1 Total Artificial Heart Industry Trends
13.2 Total Artificial Heart Market Drivers
13.3 Total Artificial Heart Market Challenges
13.4 Total Artificial Heart Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Total Artificial Heart market size was US$ 724 million in 2025 and is forecast to reach a readjusted size of US$ 1740 million by 2032 with a CAGR of 13.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 73
USD 4250.00
(Single User License)
The global Total Artificial Heart market was valued at US$ 724 million in 2025 and is anticipated to reach US$ 1740 million by 2032, at a CAGR of 13.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 2900.00
(Single User License)
The global market for Total Artificial Heart was estimated to be worth US$ 724 million in 2025 and is projected to reach US$ 1740 million, growing at a CAGR of 13.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 80
USD 3950.00
(Single User License)
The global market for Total Artificial Heart was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 88
USD 3950.00
(Single User License)
The global Total Artificial Heart market is projected to grow from US$ 641 million in 2024 to US$ 1551 million by 2031, at a CAGR of 13.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 130
USD 4900.00
(Single User License)
The global Total Artificial Heart market size was US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published Date: 2025-08-12
Pages: 65
USD 4250.00
(Single User License)
The global market for Total Artificial Heart was valued at US$ 641 million in the year 2024 and is projected to reach a revised size of US$ 1551 million by 2031, growing at a CAGR of 13.5% during the forecast period.
Published Date: 2025-08-12
Pages: 67
USD 2900.00
(Single User License)
In 2024, the global market size of Total Artificial Heart was estimated to be worth US$ 57.6 million and is forecast to reach approximately US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 109
USD 5900.00
(Single User License)
The global market for Total Artificial Heart was estimated to be worth US$ 57.6 million in 2024 and is forecast to a readjusted size of US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 88
USD 3950.00
(Single User License)
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Published Date: 2024-04-17
Pages: 137
USD 5600.00
(Single User License)
The global Total Artificial Heart market size was US$ 724 million in 2025 and is forecast to reach a readjusted size of US$ 1740 million by 2032 with a CAGR of 13.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 73
The global Total Artificial Heart market was valued at US$ 724 million in 2025 and is anticipated to reach US$ 1740 million by 2032, at a CAGR of 13.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
The global market for Total Artificial Heart was estimated to be worth US$ 724 million in 2025 and is projected to reach US$ 1740 million, growing at a CAGR of 13.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 80
The global market for Total Artificial Heart was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 88
The global Total Artificial Heart market is projected to grow from US$ 641 million in 2024 to US$ 1551 million by 2031, at a CAGR of 13.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 130
The global Total Artificial Heart market size was US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published: 2025-08-12
Pages: 65
The global market for Total Artificial Heart was valued at US$ 641 million in the year 2024 and is projected to reach a revised size of US$ 1551 million by 2031, growing at a CAGR of 13.5% during the forecast period.
Published: 2025-08-12
Pages: 67
In 2024, the global market size of Total Artificial Heart was estimated to be worth US$ 57.6 million and is forecast to reach approximately US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 109
The global market for Total Artificial Heart was estimated to be worth US$ 57.6 million in 2024 and is forecast to a readjusted size of US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 88
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Published: 2024-04-17
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now